Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London [Yahoo! Finance]
Cytosorbents Corporation (CTSO)
Last cytosorbents corporation earnings: 11/5 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cytosorbents.com
Company Research
Source: Yahoo! Finance
conditions in the intensive care unit and cardiac surgery using blood purification, today announced that management will present and participate in one-on-one meetings with investors at the Jefferies Global Healthcare Conference, being held on November 17-20, 2025 in London, United Kingdom. CytoSorbents Corporation (NASDAQ: CTSO) is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification. CytoSorbents' flagship product, CytoSorb(R), is approved in the European Union and distributed in over 70 countries worldwide. CytoSorbents is seeking U.S. FDA and Health Canada marketing approval of DrugSorb™-ATR for antithrombotic drug removal during cardiothoracic surgery. (PRNewsfoto/CytoSorbents Corporation) (PRNewsfoto/CytoSorbents Corporation) Presentation Details: Date: Tuesday, November 18, 2025 Time: 12.30 PM GMT / 7:30 AM ET Live webcast link: Jefferies – CytoSorbents Presentation Live webcast of the present
Show less
Read more
Impact Snapshot
Event Time:
CTSO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTSO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTSO alerts
High impacting Cytosorbents Corporation news events
Weekly update
A roundup of the hottest topics
CTSO
News
- Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in LondonPR Newswire
- Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.MarketBeat
- Cytosorbents (NASDAQ:CTSO) had its price target lowered by analysts at HC Wainwright from $1.00 to $0.75. They now have a "neutral" rating on the stock.MarketBeat
- Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Cytosorbents outlines cash flow breakeven targets for Q1 2026 through workforce and cost restructuring [Seeking Alpha]Seeking Alpha
CTSO
Earnings
- 11/13/25 - Beat
CTSO
Sec Filings
- 11/20/25 - Form 4
- 10/3/25 - Form 8-K
- 9/16/25 - Form 8-K
- CTSO's page on the SEC website